Linda Sasset

Senior Scientist RenBio

Linda has extensive experience in studying molecular and cellular processes, particularly in the context of cardiovascular diseases and diabetes. Her postdoctoral fellowship at Weill Cornell Medical College focused on the regulation and role of sphingolipids in health and disease. Dr. Sasset’s research has led to the discovery of Nogo-A as a negative regulator of SPT activity, which helps preserve beneficial autophagy and metabolic gene expression. Her work has been instrumental in understanding the role of sphingolipids in cardiovascular diseases and diabetes, contributing to the development of novel therapeutic strategies.

Seminars

Thursday 16th July 2026
DNA-Encoded Metabolic Transformation by Leveraging In Vivo Protein Production to Redefine Durability & Dosing Paradigms Beyond Incretin Agonism
8:30 am
  • Investigating a novel DNA-based platform for sustained in vivo GLP-1 production following a single administration
  • Examining DNA electroporation for delivery of brain-targeted incretin mimetics for precise hunger modulation
  • Assessing strategies for half-life extension of incretin to reduce dosing frequencies for improved patient adherence 

Linda Sasset